The launch of our new websites is the perfect illustration of our mission to expand and provide new and better services to our clients and industry partners.
Brooksville, FL (PRWEB) April 12, 2012
Pharmaceutical manufacturing company TG United Inc. announced today the launch of a new website designed to inform current and future customers about the company, its products and its latest news, according to a press statement by founder and Chief Executive Officer David Daniel Ambrose.
The site at tgunited.com has been in development for several months, David Daniel Ambrose said, and will offer a comprehensive list of TG United Inc.’s products, alongside updates on the latest developments in its cutting-edge laboratory. The site also will be used to post information on job openings and general updates about the pharmaceutical industry, the CEO noted.
“We launched this site to be a sort of pipeline for the products and services we offer our customers, and as resource of information on how we plan to develop into an even more important player in the industry,” David Daniel Ambrose said. “We’ve already made great strides as a national provider of critical pharmaceutical products, and as we grow and expand that mission, this site will keep everyone inside the industry and out informed about our progress and the new medicines that are becoming available.”
TG United Inc. manufactures tablet, capsule and liquid medications and provides full research and testing protocols on its Brooksville, Florida campus.
“We really tried to keep the user in mind when we developed this new website,” noted website developer Daniel Dean. “But the real reason this new site will be successful is David Daniel Ambrose. David’s a true professional who really understands this industry, and David Ambrose knew exactly what he wanted this website to say, and how he wanted it to work.”
David Daniel Ambrose brings more than 15 years of industry experience to TG United Inc. David Ambrose is also the CEO of MCR American Pharmaceuticals, a distribution company David bought in 1999 just two years after joining its sales team, and is the founder of generic pharmaceuticals provider Ambi Pharmaceuticals. David Daniel Ambrose launched TG United Inc. in 2004 and sold both TG United and Ambi to Neural High-Tech Pharmaceuticals in 2008, shortly before taking over as Neural High-Tech’s chairman and chief executive.
David Daniel Ambrose received a bachelor’s degree in finance from West Virginia University in 1990.
The launch of the new website coincides with the conclusion of a routine Federal Drug Administration inspection of TG United Inc.’s Laboratory, a three-month study that concluded this week. Once the FDA issues its findings, which David Daniel Ambrose expects to be positive, TG United Inc. will turn its focus to increasing its product offerings by purchasing new FDA drug applications from other pharmaceuticals manufacturers, the CEO noted.
The website launch is also accompanied by the similar website launch for MCR American Pharmaceuticals, which flipped the switch on the new mcramerican.com this week. That site is geared more toward physicians and practices that directly distribute MCR American Pharmaceuticals’ products, or would like to.
“This is an exciting time for our companies,” David Daniel Ambrose said. “Growth is always exciting, and the launch of our new websites is the perfect illustration of our mission to expand and provide new and better services to our clients and industry partners.”
About David Daniel Ambrose
David Daniel Ambrose is a pharmaceutical company chief executive with more than 15 years of industry experience. David Daniel Ambrose is the CEO of TG United Inc. and MCR American Pharmaceuticals, as well as parent company Neural High-Tech Pharmaceuticals, all based on Brooksville, Florida. David Daniel Ambrose received a bachelor’s degree in finance from West Virginia University in 1990 and lives in Brooksville with his wife of 18 years, Amanda, and their three children.